Back to all bills
S 998119th CongressIntroduced
Medical Supply Chain Resiliency Act
Introduced: Oct 28, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Medical Supply Chain Resiliency Act authorizes the President to negotiate trade agreements that eliminate duties or other import restrictions on medical goods to enhance national security and public health, with extensive congressional oversight, reporting, and enforcement provisions.
Key Points
- 1President may negotiate trusted trade partner agreements to reduce or eliminate duties on medical goods.
- 2Agreements must meet criteria related to transparency, IP protection, and regulatory cooperation.
- 3Congressional oversight includes notice, consultation, and a 30‑day review period for each agreement.
- 4The Trade Representative must report on negotiations and compliance every 180 days.
- 5Enforcement mechanisms allow suspension or termination of agreements if partners fail to comply.
Impact Areas
U.S. healthcare providers and patients relying on medical supplies.Foreign trade partners and manufacturers of medical goods.U.S. trade and commerce agencies, including the U.S. Trade Representative.Congressional committees on finance and ways and means.
Generated by openai/gpt-oss-20b:free on Nov 20, 2025